DRTS icon

Alpha Tau Medical

7.36 USD
+0.11
1.52%
At close Updated Mar 17, 12:03 PM EDT
1 day
1.52%
5 days
6.98%
1 month
-1.34%
3 months
53.01%
6 months
91.67%
Year to date
52.38%
1 year
176.69%
5 years
-38.2%
10 years
-38.2%
 

About: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Employees: 121

0
Funds holding %
of 8,083 funds
0
Analysts bullish %
of 3 analysts
0
Positive news %
of 4 articles
Price charts implemented using Lightweight Charts™